ConductScience.org, home

Paper9094449

Mechanisms of oral tolerance.

Garside P and 1 other. Crit Rev Immunol, 1997. Cited by 60 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Mechanisms of oral tolerance. Papers, record 9094449. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9094449

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mechanisms of oral tolerance.
PubMed
Journal
Crit Rev Immunol
PubMed
Year
1997
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
60
iCite
Relative citation ratio, by iCite
1.33
iCite
Revised in PubMed
2019-11-01
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Garside PP
2Mowat AMA M

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Immune ToleranceMajor topic
Intestinal MucosaMajor topic
Administration, Oral
Animals
Autoimmune Diseases
Clonal Anergy
Clonal Deletion
Cytokines
Dose-Response Relationship, Immunologic
Food Hypersensitivity
Humans
Immunotherapy
Inflammation
Mice

Source PubMed

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 60 citations.

PMIDTitleJournalYearIn PapersSource
20,200,594Role of CTLA-4, IL-18 and IL-10 on the Induction of Low Dose Oral Tolerance.J Ky Acad Sci2008https://conductscience.org/library/papers/20200594PubMed
17,491,673Mucosal tolerance to prevent type 1 diabetes: can the outcome be improved in humans?Rev Diabet Stud2004https://conductscience.org/library/papers/17491673PubMed
12,948,504Pilot study to assess the effects of early flea exposure on the development of flea hypersensitivity in cats.J Feline Med Surg2003https://conductscience.org/library/papers/12948504PubMed
12,390,306Effect of in vivo administration of anti-CTLA-4 monoclonal antibody and IL-12 on the induction of low-dose oral tolerance.Clin Exp Immunol2002https://conductscience.org/library/papers/12390306PubMed
11,318,549Lamina propria lymphocytes produce interferon-gamma and develop suppressor activity in response to lactoglobulin.Dig Dis Sci2001https://conductscience.org/library/papers/11318549PubMed
11,106,945Induction of specific transplantation immunity by oral immunization with allogeneic cells.Immunology2000https://conductscience.org/library/papers/11106945PubMed
10,597,372Immunotherapy for food allergies. Past, present, future.Clin Rev Allergy Immunol1999https://conductscience.org/library/papers/10597372PubMed
10,233,706Immunoglobulin E suppression and cytokine modulation in mice orally tolerized to beta-lactoglobulin.Immunology1999https://conductscience.org/library/papers/10233706PubMed
9,862,840Oral tolerance in disease.Gut1999https://conductscience.org/library/papers/9862840PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9094449

GET https://conductscience.org/api/papers/v1/9094449/authors